Cambridge Medical Robotics Ltd, the private company developing a next-generation robotic system for universal minimal access surgery, today announces the completion of its surgical system prototype.
Martin Frost, Chief Executive Officer, commented: “CMR seeks to expand the current $2.3 billion market for robotic minimal access surgery by a factor of 10 with its versatile, universal surgical robotic platform. With a fully manoeuvrable wristed system and small form factor, the system promises to make the benefits of robotic minimal access surgery accessible at a price that will be substantially lower than competing technologies.”
“The recent prototype demonstration has enabled the Company to substantiate its claims and to meet all of its pre-agreed investor milestones. This represents a huge achievement for the CMR team in under two years.”
Medical Director Mark Slack added: “Within the next decade I believe versatile surgical robotic systems will become a standard feature in operating theatres and a critical extension of the modern day surgeon. The CMR system is unique in its versatility and economic sustainability, and is an extremely valuable addition to the surgical robotic market, enabling many more surgeons to deliver keyhole surgical procedures to a broader spectrum of patients.”
About the CMR surgical robotic system
CMR’s modular system uses multiple collaborative robotic arms, which, sensitive to applied forces, mimic the movements of a surgeon and can be easily repositioned around an operating theatre. The system offers state-of-the-art 3D high-definition imagery, and also provides the surgeon with force feedback to assist in delicate procedures.
The CMR robotic arm and end-of-arm surgical instruments provide significantly enhanced flexibility, mimicking the dexterity of the surgeon’s hands. This life-like sensitivity and usability has so far been lacking in current surgical robotic systems on the market.
The system overcomes the obstacles to widespread adoption of robotic minimal access surgery, namely robot size, instrument size, versatility, port placement, cost and ease of use, allowing the system to be highly utilised and cost-comparable to manual laparoscopic surgery. The system’s official name will be announced in due course.